Clemens, J.
Mühlbauer, E.
Reinhard, I.
Bauer, M.
Neubauer, A. B.
Ritter, P.
Ludwig, V. M.
Severus, W. E.
Ebner-Priemer, U. W.
Schmitz, S. E.
Funding for this research was provided by:
Technische Universität Dresden
Article History
Received: 24 December 2024
Accepted: 24 September 2025
First Online: 27 October 2025
Declarations
:
: This study was conducted in accordance with the Declaration of Helsinki. Ethical approval was obtained from the Institutional Review Board (IRB) of the University of Dresden (DE/EKSN38, reference number: 26012014). All participants provided written informed consent before receiving a study smartphone (optional) and reimbursement of 35 € per month.
: Not applicable.
: UE-P reports consultancy for Boehringer-Ingelheim and speaker honorarium from Angelini Pharma.